{"title":"A nanoDiamond/gold nanoparticle-based electrochemical immunosensor for the detection of HER 2 cancer biomarker","authors":"Foluke O.G. Olorundare , Sesethu Makaluza , Nyasha Midzi , Omotayo A. Arotiba , Duduzile Nkosi","doi":"10.1016/j.biosx.2024.100483","DOIUrl":null,"url":null,"abstract":"<div><p>We report a highly sensitive electrochemical immunosensor based on a nanohybrid platform for the detection of the breast cancer biomarker human epidermal growth factor receptor 2 (HER 2). NanoDiamond (nanoD) and gold nanoparticles (AuNPs) immobilised by drop coating and electrodeposition methods, respectively, were employed to fabricate an immunosensor for HER 2 detections on a glassy carbon electrode (GCE). Voltammetry and electrochemical impedance spectroscopy (EIS) techniques were used to characterise each step of the modification process of the immunosensor. In addition, transmission electron microscopy (TEM), X-ray diffraction (XRD) and field emission scanning electron microscopy (FESEM) techniques were used to characterise the materials used to fabricate the modified electrode. Under optimal conditions of temperature, time, and pH (35 °C, 50 min, and pH 7.2), different concentrations were investigated within a wide range of 1 pg mL<sup>−1</sup> to 50 ng mL<sup>−1</sup> using differential pulse voltammetry (DPV). With a low detection limit of 0.29 pg mL<sup>−1</sup> from the DPV analysis, the immunosensor showed very good sensitivity and had a high specificity for HER 2. Additionally, the immunosensor demonstrated good applicability in the analysis of HER 2 in human serum samples, demonstrating a potential for use in the early identification of breast cancer.</p></div>","PeriodicalId":260,"journal":{"name":"Biosensors and Bioelectronics: X","volume":"18 ","pages":"Article 100483"},"PeriodicalIF":10.6100,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590137024000475/pdfft?md5=172b114ab36084f1e8378156430e53df&pid=1-s2.0-S2590137024000475-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biosensors and Bioelectronics: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590137024000475","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
Abstract
We report a highly sensitive electrochemical immunosensor based on a nanohybrid platform for the detection of the breast cancer biomarker human epidermal growth factor receptor 2 (HER 2). NanoDiamond (nanoD) and gold nanoparticles (AuNPs) immobilised by drop coating and electrodeposition methods, respectively, were employed to fabricate an immunosensor for HER 2 detections on a glassy carbon electrode (GCE). Voltammetry and electrochemical impedance spectroscopy (EIS) techniques were used to characterise each step of the modification process of the immunosensor. In addition, transmission electron microscopy (TEM), X-ray diffraction (XRD) and field emission scanning electron microscopy (FESEM) techniques were used to characterise the materials used to fabricate the modified electrode. Under optimal conditions of temperature, time, and pH (35 °C, 50 min, and pH 7.2), different concentrations were investigated within a wide range of 1 pg mL−1 to 50 ng mL−1 using differential pulse voltammetry (DPV). With a low detection limit of 0.29 pg mL−1 from the DPV analysis, the immunosensor showed very good sensitivity and had a high specificity for HER 2. Additionally, the immunosensor demonstrated good applicability in the analysis of HER 2 in human serum samples, demonstrating a potential for use in the early identification of breast cancer.
期刊介绍:
Biosensors and Bioelectronics: X, an open-access companion journal of Biosensors and Bioelectronics, boasts a 2020 Impact Factor of 10.61 (Journal Citation Reports, Clarivate Analytics 2021). Offering authors the opportunity to share their innovative work freely and globally, Biosensors and Bioelectronics: X aims to be a timely and permanent source of information. The journal publishes original research papers, review articles, communications, editorial highlights, perspectives, opinions, and commentaries at the intersection of technological advancements and high-impact applications. Manuscripts submitted to Biosensors and Bioelectronics: X are assessed based on originality and innovation in technology development or applications, aligning with the journal's goal to cater to a broad audience interested in this dynamic field.